750
Participants
Start Date
January 1, 2019
Primary Completion Date
January 1, 2026
Study Completion Date
October 1, 2030
Left atrial appendage occlusion
Interventional left atrial appendage occlusion with the Amulet or Watchman device
NOAC
Medical treatment arm. Patients will be treated with one of the available NOAC drugs; Apixaban, Dabigatran, Edoxaban or Rivaroxaban. The specific drug and dose is at the discretion of the treating physician.
ACTIVE_NOT_RECRUITING
Odense University Hospital, Odense
RECRUITING
Haukeland University Hospital, Bergen
RECRUITING
Aarhus University Hospital, Aarhus
RECRUITING
Aalborg University Hospital, Aalborg
RECRUITING
Karolinska University Hospital, Stockholm
NOT_YET_RECRUITING
Turku University Hospital, Turku
RECRUITING
Sahlgrenska University Hospital, Gothenburg
NOT_YET_RECRUITING
Rigshospitalet, Copenhagen
RECRUITING
Regional Hospital West Jutland, Holstebro
RECRUITING
Helsinki University Central Hospital, Helsinki
WITHDRAWN
Oulu University Hospital, Oulu
RECRUITING
Jena University Hospital, Jena
RECRUITING
Oslo University Hospital, Oslo
NOT_YET_RECRUITING
Trondheim University Hospital, Trondheim
NOT_YET_RECRUITING
Skånes University Hospital, Lund
Aarhus University Hospital
OTHER
Aalborg University Hospital
OTHER
Odense University Hospital
OTHER
Sahlgrenska University Hospital
OTHER
Karolinska University Hospital
OTHER
Haukeland University Hospital
OTHER
Helsinki University Central Hospital
OTHER
Gødstrup Hospital
OTHER
Lund University Hospital
OTHER
Oslo University Hospital
OTHER
Trondheim University Hospital
OTHER
Rigshospitalet, Denmark
OTHER
Jena University Hospital
OTHER
University of Aarhus
OTHER